Literature DB >> 31541304

A rare cause of hypertension in childhood: Answers.

Nuran Kucuk1, Zehra Yavas Abalı2, Saygın Abalı3, Nur Canpolat4, Gozde Yesil5, Serap Turan2, Abdullah Bereket2, Tulay Guran6.   

Abstract

Entities:  

Keywords:  Apparent mineralocorticoid excess; HSD11B2 gene; Low renin hypertension

Mesh:

Substances:

Year:  2019        PMID: 31541304     DOI: 10.1007/s00467-019-04329-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  16 in total

1.  Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated.

Authors:  J W Funder; P T Pearce; R Smith; A I Smith
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

2.  A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess.

Authors:  R C Wilson; Z S Krozowski; K Li; V R Obeyesekere; M Razzaghy-Azar; M D Harbison; J Q Wei; C H Shackleton; J W Funder; M I New
Journal:  J Clin Endocrinol Metab       Date:  1995-07       Impact factor: 5.958

3.  Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency.

Authors:  Mabel Yau; Shozeb Haider; Ahmed Khattab; Chen Ling; Mehr Mathew; Samir Zaidi; Madison Bloch; Monica Patel; Sinead Ewert; Wafa Abdullah; Aysenur Toygar; Vitalii Mudryi; Maryam Al Badi; Mouch Alzubdi; Robert C Wilson; Hanan Said Al Azkawi; Hatice Nur Ozdemir; Wahid Abu-Amer; Jozef Hertecant; Maryam Razzaghy-Azar; John W Funder; Aisha Al Senani; Li Sun; Se-Min Kim; Tony Yuen; Mone Zaidi; Maria I New
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-11       Impact factor: 11.205

4.  Deletion of claudin-10 (Cldn10) in the thick ascending limb impairs paracellular sodium permeability and leads to hypermagnesemia and nephrocalcinosis.

Authors:  Tilman Breiderhoff; Nina Himmerkus; Marchel Stuiver; Kerim Mutig; Constanze Will; Iwan C Meij; Sebastian Bachmann; Markus Bleich; Thomas E Willnow; Dominik Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

5.  Apparent mineralocorticoid excess and the long term treatment of genetic hypertension.

Authors:  Maryam Razzaghy-Azar; Mabel Yau; Ahmed Khattab; Maria I New
Journal:  J Steroid Biochem Mol Biol       Date:  2016-02-15       Impact factor: 4.292

Review 6.  Diagnostic approach to low-renin hypertension.

Authors:  Silvia Monticone; Isabel Losano; Martina Tetti; Fabrizio Buffolo; Franco Veglio; Paolo Mulatero
Journal:  Clin Endocrinol (Oxf)       Date:  2018-06-06       Impact factor: 3.478

7.  Hypokalemia Associated With a Claudin 10 Mutation: A Case Report.

Authors:  Nicole Meyers; Carol Nelson-Williams; Laura Malaga-Dieguez; Horacio Kaufmann; Erin Loring; James Knight; Richard P Lifton; Howard Trachtman
Journal:  Am J Kidney Dis       Date:  2018-10-25       Impact factor: 8.860

8.  Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene.

Authors:  P M Stewart; Z S Krozowski; A Gupta; D V Milford; A J Howie; M C Sheppard; C B Whorwood
Journal:  Lancet       Date:  1996-01-13       Impact factor: 79.321

9.  An abnormality in steroid reductive metabolism in a hypertensive syndrome.

Authors:  S Ulick; L C Ramirez; M I New
Journal:  J Clin Endocrinol Metab       Date:  1977-04       Impact factor: 5.958

Review 10.  The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Evans; Matthew Hayden; Sally Heywood; Michelle Hussain; Andrew D Phillips; David N Cooper
Journal:  Hum Genet       Date:  2017-03-27       Impact factor: 4.132

View more
  1 in total

1.  A clinical approach to tubulopathies in children and young adults.

Authors:  Andrew Mallett; Hugh McCarthy; Rachael Kermond
Journal:  Pediatr Nephrol       Date:  2022-05-18       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.